In 2015, another double-blind RCT reported significant improvements in pain associated with aphthous ulcers with a B12 ointment compared with a B12-free ointment
Research-grade material sold under these names is intended for laboratory use only and is not for human or veterinary consumption
Bergendi, L., Benes, L., Durackova, Z
It stimulates insulin secretion from your pancreas, reduces glucagon (a hormone that increases blood sugar), slows stomach emptying, and promotes a feeling of fullness
Peptides work at the cellular level, stimulating natural growth hormone release, tissue repair, and fat metabolism
The Substances on the Table These are the drugs being reviewed and the medical uses FDA will be evaluating: July 23, 2026: BPC-157 (free base and acetate) ulcerative colitis KPV (free base and acetate) wound healing and inflammatory conditions TB-500 (free base and acetate) wound healing MOTs-C (free base and acetate) obesity and osteoporosis July 24, 2026: Emideltide / DSIP (delta sleep-inducing peptide, free base and acetate) opioid withdrawal, chronic insomnia, and narcolepsy Semax (free base and acetate) cerebral ischemia, migraine, and trigeminal neuralgia Epitalon (free base and acetate) insomnia If any or all of these substances are added to the 503A Bulks List following this process, it would formalize the legal pathway for licensed pharmacists and physicians to compound them for patients